These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[X]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
(State or other jurisdiction of
incorporation or organization)
|
57-0426694
(IRS Employer
Identification Number)
|
|
|
775 Spartan Blvd. Suite 102
Spartanburg, South Carolina
(Address of principal executive offices)
|
29301
(Zip code)
|
|
(864) 585-3605
(Registrant's telephone number, including area code) |
|
Larger accelerated filer ( )
|
Accelerated filer ( X )
|
|
Non-accelerated filer ( )
(Do not check if a smaller reporting company)
|
Smaller reporting company ( )
|
|
Item 1.
|
Financial Statements (unaudited)
|
|
Condensed consolidated balance sheets - March 31, 2012 and December 31, 2011
|
|
|
Condensed consolidated statements of operations - Three months ended March 31, 2012 and
April 2, 2011
|
|
|
Condensed consolidated statements of cash flows - Three months ended March 31, 2012 and
April 2, 2011
|
|
|
Notes to condensed consolidated financial statements
|
|
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
|
Item 4.
|
Controls and Procedures
|
|
Item 6.
|
Exhibits
|
|
Signatures and Certifications
|
|
|
||||||||
|
|
||||||||
|
Synalloy Corporation
|
||||||||
|
|
(Unaudited)
|
|||||||
|
Mar 31, 2012
|
Dec 31, 2011
|
|||||||
|
Assets
|
||||||||
|
Current assets
|
||||||||
|
Cash and cash equivalents
|
$ | 114,583 | $ | 110,138 | ||||
|
Accounts receivable, less allowance
|
||||||||
|
for doubtful accounts
|
32,621,367 | 26,582,279 | ||||||
|
Inventories
|
||||||||
|
Raw materials
|
14,003,668 | 10,120,408 | ||||||
|
Work-in-process
|
12,128,598 | 12,632,301 | ||||||
|
Finished goods
|
17,695,066 | 20,310,029 | ||||||
|
Total inventories
|
43,827,332 | 43,062,738 | ||||||
|
Deferred income taxes
|
2,565,077 | 2,632,145 | ||||||
|
Prepaid expenses and other current assets
|
1,566,401 | 2,250,735 | ||||||
|
Total current assets
|
80,694,760 | 74,638,035 | ||||||
|
Cash value of life insurance
|
2,519,660 | 3,092,430 | ||||||
|
Property, plant & equipment, net of accumulated
|
||||||||
|
depreciation of $40,316,438 and $39,833,076
|
18,496,411 | 18,713,524 | ||||||
|
Goodwill
|
2,354,730 | 2,354,730 | ||||||
|
Deferred charges, net and other non-current assets
|
111,372 | 117,645 | ||||||
|
Total assets
|
$ | 104,176,933 | $ | 98,916,364 | ||||
|
Liabilities and Shareholders' Equity
|
||||||||
|
Current liabilities
|
||||||||
|
Accounts payable
|
$ | 18,053,688 | $ | 13,043,153 | ||||
|
Accrued expenses
|
5,948,973 | 5,112,662 | ||||||
|
Current portion of environmental reserves
|
149,055 | 138,000 | ||||||
|
Total current liabilities
|
24,151,716 | 18,293,815 | ||||||
|
Long-term debt
|
6,683,405 | 8,650,431 | ||||||
|
Environmental reserves
|
502,000 | 502,000 | ||||||
|
Deferred compensation
|
292,805 | 293,555 | ||||||
|
Deferred income taxes
|
2,557,662 | 2,557,662 | ||||||
|
Shareholders' equity
|
||||||||
|
Common stock, par value $1 per share - authorized
|
||||||||
|
12,000,000 shares; issued 8,000,000 shares
|
8,000,000 | 8,000,000 | ||||||
|
Capital in excess of par value
|
1,089,389 | 1,153,889 | ||||||
|
Retained earnings
|
75,535,420 | 74,198,151 | ||||||
|
Less cost of common stock in treasury:
|
||||||||
|
1,663,057 and 1,674,156 shares
|
(14,635,464 | ) | (14,733,139 | ) | ||||
|
Total shareholders' equity
|
69,989,345 | 68,618,901 | ||||||
|
Total liabilities and shareholders' equity
|
$ | 104,176,933 | $ | 98,916,364 | ||||
|
Note: The balance sheet at December 31, 2011 has been derived from the audited consolidated financial statements at that date.
|
||||||||
|
See accompanying notes to condensed consolidated financial statements.
|
||||||||
|
Synalloy Corporation
|
||||||||
|
|
||||||||
|
(Unaudited)
|
Three Months Ended
|
|||||||
|
Mar 31, 2012
|
Apr 2, 2011
|
|||||||
|
Net sales
|
$ | 47,372,076 | $ | 42,742,420 | ||||
|
Cost of goods sold
|
42,281,163 | 35,644,239 | ||||||
|
Gross profit
|
5,090,913 | 7,098,181 | ||||||
|
Selling, general and administrative expense
|
3,121,561 | 3,134,689 | ||||||
|
Operating income
|
1,969,352 | 3,963,492 | ||||||
|
Other (income) and expense
|
||||||||
|
Interest expense
|
46,231 | 29,171 | ||||||
|
Other, net
|
(135,148 | ) | (14 | ) | ||||
|
Income before income taxes
|
2,058,269 | 3,934,335 | ||||||
|
Provision for income taxes
|
721,000 | 1,434,000 | ||||||
|
Net income
|
$ | 1,337,269 | $ | 2,500,335 | ||||
|
Net income per common share:
|
||||||||
|
Basic
|
$ | 0.21 | $ | 0.40 | ||||
|
Diluted
|
$ | 0.21 | $ | 0.39 | ||||
|
Weighted average shares outstanding:
|
||||||||
|
Basic
|
6,328,771 | 6,295,855 | ||||||
|
Dilutive effect from stock
|
||||||||
|
options and grants
|
49,778 | 41,836 | ||||||
|
Diluted
|
6,378,549 | 6,337,691 | ||||||
|
See accompanying notes to condensed consolidated financial statements.
|
||||||||
|
|
||||||||
|
(Unaudited)
|
Three Months Ended,
|
|||||||
|
Mar 31, 2012
|
Apr 2, 2011
|
|||||||
|
Operating activities
|
||||||||
|
Net income
|
$ | 1,337,269 | $ | 2,500,335 | ||||
|
Adjustments to reconcile net income to net cash provided by
|
||||||||
|
(used in) operating activities:
|
||||||||
|
Depreciation expense
|
706,341 | 767,829 | ||||||
|
Amortization of deferred charges
|
6,273 | 5,340 | ||||||
|
Deferred income taxes
|
67,068 | 62,072 | ||||||
|
Provision for (reduction of) losses on accounts receivable
|
(96,000 | ) | (54,000 | ) | ||||
|
Provision for (reduction of) losses on inventory
|
286,250 | (53,000 | ) | |||||
|
Gain on sale of property, plant and equipment
|
(41,724 | ) | (2,950 | ) | ||||
|
Cash value of life insurance
|
(161,436 | ) | (18,001 | ) | ||||
|
Environmental reserves
|
11,055 | 8,016 | ||||||
|
Employee stock option and stock grant compensation
|
78,251 | 74,928 | ||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
(5,943,088 | ) | (9,403,803 | ) | ||||
|
Inventories
|
(1,050,844 | ) | (10,566,879 | ) | ||||
|
Other assets and liabilities
|
57,890 | 78,574 | ||||||
|
Accounts payable
|
5,010,535 | 8,976,031 | ||||||
|
Accrued expenses
|
797,767 | 2,391,466 | ||||||
|
Income taxes payable
|
619,162 | 1,349,913 | ||||||
|
Net cash provided by (used in) operating activities
|
1,684,769 | (3,884,129 | ) | |||||
|
Investing activities
|
||||||||
|
Purchases of property, plant and equipment
|
(525,004 | ) | (457,910 | ) | ||||
|
Proceeds from sale of property, plant and equipment
|
77,500 | 2,950 | ||||||
|
Proceeds from life insurance
|
734,206 | - | ||||||
|
Net cash provided by (used in) investing activities
|
286,702 | (454,960 | ) | |||||
|
Financing activities
|
||||||||
|
Net (payments on) borrowings from long-term debt
|
(1,967,026 | ) | 5,118,847 | |||||
|
Proceeds from exercised stock options
|
- | 550 | ||||||
|
Net cash (used in) provided by financing activities
|
(1,967,026 | ) | 5,119,397 | |||||
|
Increase in cash and cash equivalents
|
4,445 | 780,308 | ||||||
|
Cash and cash equivalents at beginning of period
|
110,138 | 108,902 | ||||||
|
Cash and cash equivalents at end of period
|
$ | 114,583 | $ | 889,210 | ||||
|
See accompanying notes to condensed consolidated financial statements.
|
||||||||
|
THREE MONTHS ENDED
|
||||||||
|
Mar 31, 2012
|
Apr 2, 2011
|
|||||||
|
Net sales
|
||||||||
|
Metals Segment
|
$ | 36,022,000 | $ | 31,417,000 | ||||
|
Specialty Chemicals Segment
|
11,350,000 | 11,325,000 | ||||||
| $ | 47,372,000 | $ | 42,742,000 | |||||
|
Operating income
|
||||||||
|
Metals Segment
|
$ | 1,571,000 | $ | 3,955,000 | ||||
|
Specialty Chemicals Segment
|
1,129,000 | 773,000 | ||||||
| 2,700,000 | 4,728,000 | |||||||
|
Unallocated expenses
|
||||||||
|
Corporate
|
731,000 | 765,000 | ||||||
|
Interest expense
|
46,000 | 29,000 | ||||||
|
Other income
|
(135,000 | ) | - | |||||
|
Income before income taxes
|
$ | 2,058,000 | $ | 3,934,000 | ||||
|
·
|
Level 1
– Quoted prices (unadjusted) in active markets for identical assets or liabilities.
|
|
·
|
Level 2
– Inputs other than quoted prices that are observable for assets and liabilities, either directly or indirectly. These inputs include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are less active.
|
|
·
|
Level 3
– Unobservable inputs that are supported by little or no market activity for assets or liabilities and includes certain pricing models, discounted cash flow methodologies and similar techniques.
|
|
Item 6.
|
Exhibits
|
|
|
The following exhibits are included herein:
|
||
|
31.1
|
Rule 13a-14(a)/15d-14(a) Certifications of Chief Executive Officer
|
|
|
31.2
|
Rule 13a-14(a)/15d-14(a) Certifications of Chief Financial Officer and Principal Accounting Officer
|
|
|
32
|
Certifications Pursuant to 18 U.S.C. Section 1350
|
|
|
101.INS*
|
XBRL Instance Document
|
|
|
101.SCH*
|
XBRL Taxonomy Extension Schema
|
|
|
101.CAL*
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
|
101.LAB*
|
XBRL Taxonomy Extension Label Linkbase
|
|
|
101.PRE*
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
SYNALLOY CORPORATION
|
||
|
(Registrant)
|
||
|
Date
:
May 8, 2012
|
By:
|
/s/ Craig C. Bram
|
|
Craig C. Bram
|
||
|
President and Chief Executive Officer
|
||
|
Date:
May 8, 2012
|
By:
|
/s/ Richard D. Sieradzki
|
|
Richard D. Sieradzki
|
||
|
Chief Financial Officer and Principal Accounting Officer
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|